Company characteristics
Assessed report publication year |
|
Financial year end |
31/12/23 |
Sector |
Health Care |
Head office |
United Kingdom |
Primary listing |
London Stock Exchange |
GBP market cap |
62,526,116,754 |
Net profit margin |
17.5% |
CEO tenure |
6.7 years |
Employee count |
70,212 |
FRF draft assessment response |
 |
Reward scrutiny
Living wage accredited |
 |
Living wage (calculation for operating regions) |
 |
Living hours accredited |
 |
Tax reporting (GRI 207) |
 |
Remuneration policies
Remuneration committee 100% independent |
 |
Remuneration committee discretion applied |
 |
Director from workforce |
 |
Trade union relations (disclosure) |
 |
Worker consultation on top pay (disclosure) |
 |
80%+ shareholder support on pay |
 |
Reward outcomes
CEO total pay (GBP) |
12,718,000 |
CEO total pay change |
50.46% |
CEO pay ratio (to median employee) |
152:1 |
Percentage point increase in maximum variable remuneration |
— |
Pension award parity between CEO and wider workforce |
 |
Pay of the next highest exec compared to CEO |
— |
Gender pay gap (mean data) |
-0.50% |
Gender pay (women % in top quartile) |
47.11% |
Ethnicity pay gap (disclosure) |
 |
Total dividend (GBP) |
2,352,000,000 |